
Enzalutamide 80 mg (Enzyl) is an anti-androgen medicine used to treat prostate cancer, including metastatic and castration-resistant prostate cancer. It works by blocking the effects of male hormones (androgens), such as testosterone, which help prostate cancer cells grow. By slowing cancer progression, it helps improve disease control and supports long-term treatment under the supervision of an oncologist.
| Generic name | Enzalutamide |
| Strength | 80 mg |
| Manufacturer | Sun Pharmaceutical |
| Package size | 56 Capsules |
| Used for | Metastatic and castration-resistant prostate cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Enzalutamide is an androgen receptor inhibitor that blocks the action of testosterone and other male hormones on prostate cancer cells. This prevents cancer cells from growing and dividing, helping slow the spread and progression of prostate cancer.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.